The Femtosecond Laser in Residency Training (FLIRT) Pilot Study
Status
Conditions
Treatments
Details and patient eligibility
About
This pilot study aims to primarily assess the rate of complication of anterior vitrectomy for patients undergoing femtosecond laser-assisted (FLA) cataract extraction and intraocular lens placement (CEIOL) compared to manual CEIOL, when performed by resident physicians under direct attending supervision. In this pilot study, the investigators aim to assess what the incidence of anterior vitrectomy is for each group, in order to better understand the sample size needed to assess whether there is a difference between these two groups. Secondarily, it will gather preliminary data on safety and refractive outcomes for patients undergoing these interventions.
Sex
Ages
Volunteers
Inclusion criteria
- Patients of the Los Angeles County + University of Southern California Medical Center (LAC+USC) who are 40 years or older with visually significant cataracts asking for surgical intervention.
- Cataract must be visually and clinically significant on examination as determined by the resident surgeon and the attending physician.
Exclusion criteria
- Age less than 40
- Visual acuity 20/30 or better with refraction in the study eye
- Any previous ocular surgery
- Patient request for monovision or for correction at near at the expense of distance
- Patient and physician decision to use an IOL implant other than monofocal IOL
- Corneal pathology (e.g. Fuch's dystrophy, corneal opacity or scar, corneal ectasia)
- Posterior or anterior capsular plaque
- Posterior polar cataract
- White cataract
- Subluxated lens, weak zonules, or phacodonesis
- Pseudoexfoliation syndrome
- Failure of preoperative pupillary dilatation (< 6 mm dilation)
- History of uveitis
- History of retinal detachment
- Untreated or active proliferative diabetic retinopathy
- Untreated or active diabetic macular edema
- Ocular diseases that may affect visual acuity or the operation (including and not limited to macular degeneration, retinitis pigmentosa, macular hole, advanced or end-stage glaucoma)
- Neurological or systemic diseases that may affect visual acuity or the safety of the operation
Trial design
Primary purpose
Allocation
Interventional model
Masking
0 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal